(Q40610954)

22 September 2017

Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors (English)

1 reference

22 September 2017

Esperanza Arias

1

0 references

Maria F Cano-Abad

object named as

María F Cano-Abad

4

0 references

Manuela López

object named as

Manuela G López

7

0 references

Antonio G. García

object named as

Antonio G García

6

0 references

author name string

Eva Alés

2

1 reference

PubMed ID

14654102

22 September 2017

Nelson H Gabilan

3

1 reference

PubMed ID

14654102

22 September 2017

Mercedes Villarroya

5

1 reference

22 September 2017

1 January 2004

1 reference

22 September 2017

1 reference

22 September 2017

46

1 reference

22 September 2017

1

1 reference

22 September 2017

103-114

1 reference

Nicotinic acetylcholine receptors on hippocampal neurons: distribution on the neuronal surface and modulation of receptor activity.

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Central nicotinic receptors, neurotrophic factors and neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Pharmacologic treatments of dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Primary structure of an agonist binding subunit of the nicotinic acetylcholine receptor from bovine adrenal chromaffin cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Differential expression of alpha-bungarotoxin-sensitive neuronal nicotinic receptors in adrenergic chromaffin cells: a role for transcription factor Egr-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Nicotine modulates the spontaneous synaptic activity in cultured embryonic rat spinal cord interneurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Nicotinic acetylcholine receptors in human neuroblastoma (SH-SY5Y) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Problems of cell death in neurodegeneration and Alzheimer's Disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Unmasking the functions of the chromaffin cell alpha7 nicotinic receptor by using short pulses of acetylcholine and selective blockers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Nicotinic alpha 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Kinetics of aggregation of synthetic beta-amyloid peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Nicotine rescues PC12 cells from death induced by nerve growth factor deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900317-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0028-3908(03)00317-4

1 reference

22 September 2017

1 reference

PubMed ID

14654102